APOBEC3B and breast carcinoma: First, we evaluated whether the calculated APOBEC3B copy number values could predict the clinical outcome of first-line tamoxifen therapy in a cohort of 329 hormone-naive breast cancer patients with ER-positive primary breast cancer.